Literature DB >> 34233389

Advances in poly(rC)-binding protein 2: Structure, molecular function, and roles in cancer.

Chendong Yuan1, Mingxiang Chen2, Xiaolu Cai3.   

Abstract

Poly(rC)-binding protein 2 (PCBP2) is an RNA-binding protein that is characterized by its ability to interact with poly(C) with high affinity in a sequence-specific manner. PCBP2 contains three K homology domains, which are consensus RNA-binding domains that play a role in recognizing and combining with RNA and DNA. The specific structure and localization of PCBP2 lay the foundation for its multiple roles in transcriptional, posttranscriptional, and translational processes, even in iron metabolism. Numerous studies have indicated that PCBP2 expression is increased in many cancer types. PCBP2 is considered as an oncogene that promotes tumorigenesis, development of cancer cells, and metastasis. Here, we summarized the current evidence regarding PCBP2 in the proliferation, migration, invasion of cancer cells, and drug resistance, aiming to clarify the molecular mechanisms of PCBP2 in cancer. Results from this review suggest that an in-depth study of PCBP2 in cancer may provide novel biomarkers for prognostic or therapeutic purposes.
Copyright © 2021 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarker; Cancer; Function; Molecular mechanisms; PCBP2; Therapeutics

Year:  2021        PMID: 34233389     DOI: 10.1016/j.biopha.2021.111719

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  4 in total

1.  Eucommia ulmoides Oliver-Tribulus terrestris L. Drug Pair Regulates Ferroptosis by Mediating the Neurovascular-Related Ligand-Receptor Interaction Pathway- A Potential Drug Pair for Treatment Hypertension and Prevention Ischemic Stroke.

Authors:  Qian Zhang; Jie Yang; Chuanhua Yang; Xuesong Yang; Yongzhi Chen
Journal:  Front Neurol       Date:  2022-03-08       Impact factor: 4.003

2.  The RNA-binding protein PCBP1 represses lung adenocarcinoma progression by stabilizing DKK1 mRNA and subsequently downregulating β-catenin.

Authors:  Yujia Zheng; Zheng Zhou; Ran Wei; Chu Xiao; Hao Zhang; Tao Fan; Bo Zheng; Chunxiang Li; Jie He
Journal:  J Transl Med       Date:  2022-07-30       Impact factor: 8.440

3.  PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer.

Authors:  Liliang Shen; Junfeng Zhang; Zongtai Zheng; Fuhan Yang; Shenghua Liu; Yuan Wu; Yifan Chen; Tianyuan Xu; Shiyu Mao; Yang Yan; Wei Li; Wentao Zhang; Xudong Yao
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

4.  Iron as spirit of life to share under monopoly.

Authors:  Shinya Toyokuni; Yingyi Kong; Hao Zheng; Yuki Maeda; Yashiro Motooka; Shinya Akatsuka
Journal:  J Clin Biochem Nutr       Date:  2022-07-27       Impact factor: 3.179

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.